// App-Quantinova.ai

FRI0363 : CLINICAL PREDICTORS OF SECUKINUMAB RETENTION IN A REAL WORLD COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS

Researchers

Presenter

  • A. Tindell

Principal Investigators

  • A. Mcgucken

  • S. Batool

  • S. Siebert

Medical Centers

  • University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom

  • NHS Greater Glasgow & Clyde, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Psoriatic arthritis

  • Spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • BMS Infotech

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved